A multicentre randomised placebo controlled clinical trial of metformin versus placebo in pregnant women to reduce the risk of obesity and metabolic syndrome in their babies.

Trial Profile

A multicentre randomised placebo controlled clinical trial of metformin versus placebo in pregnant women to reduce the risk of obesity and metabolic syndrome in their babies.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Sep 2016

At a glance

  • Drugs Metformin (Primary)
  • Indications Metabolic syndrome; Obesity
  • Focus Registrational; Therapeutic Use
  • Acronyms EMPOWaR
  • Most Recent Events

    • 13 Aug 2015 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
    • 05 Nov 2014 Planned End Date changed from 31 Jan 2014 to 30 Apr 2015, according to ISRCTN: Current Controlled Trials.
    • 07 Feb 2014 Accrual to date is 112% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top